...
首页> 外文期刊>Movement disorders >How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
【24h】

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy

机译:如何应用运动障碍社会标准进行诊断进行进步血清核麻痹

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background The Movement Disorder Society criteria for progressive supranuclear palsy define diagnostic allocations, stratified by certainty levels and clinical predominance types. We aimed to study the frequency of ambiguous multiple allocations and to develop rules to eliminate them. Methods We retrospectively collected standardized clinical data by chart review in a multicenter cohort of autopsy‐confirmed patients with progressive supranuclear palsy, to classify them by diagnostic certainty level and predominance type and to identify multiple allocations. Results Comprehensive data were available from 195 patients. More than one diagnostic allocation occurred in 157 patients (80.5%). On average, 5.4 allocations were possible per patient. We developed four rules for Multiple Allocations eXtinction (MAX). They reduced the number of patients with multiple allocations to 22 (11.3%), and the allocations per patient to 1.1. Conclusions The proposed MAX rules help to standardize the application of the Movement Disorder Society criteria for progressive supranuclear palsy. ? 2019 International Parkinson and Movement Disorder Society
机译:摘要背景流动紊乱的进展性疾病社会标准定义诊断分配,通过确定性水平和临床优势类型分层。我们旨在研究模棱两可分配的频率并制定消除它们的规则。方法通过诊断确定水平和优势类型,回顾性地回顾性地收集标准化的临床数据,以通过综合尸检患者的尸检证实患者进行分类,分类它们,并识别多重分配。结果从195名患者提供全面数据。 157名患者发生了多于一种诊断分配(80.5%)。平均而言,每位患者可能有5.4个拨款。我们开发了四个规则,用于多分配灭绝(最大值)。他们将多重分配的患者的数量减少到22(11.3%),每位患者的分配到1.1。结论拟议的最大规则有助于标准化运动障碍社会标准的应用程序进行进步性激性麻痹。还2019年国际帕金森和运动障碍协会

著录项

  • 来源
    《Movement disorders 》 |2019年第8期| 共5页
  • 作者单位

    Department of NeurologyTechnische Universit?t MünchenMunich Germany;

    Department of NeurologyTechnische Universit?t MünchenMunich Germany;

    Second Department of NeurologyAttikon University Hospital University of AthensAthens Greece;

    German Center for Neurodegenerative Diseases (DZNE)Munich Germany;

    Division of NeurologyRoyal University Hospital University of SaskatchewanSaskatoon Saskatchewan;

    Neurological Tissue Bank and Neurology DepartmentHospital Clínic de Barcelona Universitat de;

    Center for Neuropathology and Prion ResearchLudwig‐Maximilians‐Universit?tMunich Germany;

    Frontotemporal Degeneration Center Department of NeurologyUniversity of PennsylvaniaPhiladelphia;

    Frontotemporal Degeneration Center Department of NeurologyUniversity of PennsylvaniaPhiladelphia;

    Department of NeurologyJohns Hopkins UniversityBaltimore Maryland USA;

    Division of NeurologyRoyal University Hospital University of SaskatchewanSaskatoon Saskatchewan;

    Center for Neuropathology and Prion ResearchLudwig‐Maximilians‐Universit?tMunich Germany;

    Department of NeurologyErasmus Medical CentreRotterdam The Netherlands;

    London Neurodegenerative Diseases Brain BankInstitute of Psychiatry Psychology and Neuroscience;

    Parkinson and Movement Disorders Unit IRCCS Hospital San Camillo Venice and Department of;

    Sobell Department of Motor Neuroscience and Movement DisordersUCL Institute of NeurologyQueen;

    Department of NeurologySanta Maria University Hospital of TerniTerni Italy;

    Departments of Nuclear Medicine and NeurologyUniversity of CologneCologne Germany;

    Department of NeurologyUniversity of UlmUlm Germany;

    German Center for Neurodegenerative Diseases (DZNE)Munich Germany;

    Univ. de Bordeaux Institut des Maladies NeurodégénérativesUMR 5293 Bordeaux France;

    Department of Clinical Sciences Division of NeurologyLund UniversityLund Sweden;

    Department of NeurologyPhilipps Universit?tMarburg Germany;

    Department of NeurologyTechnische Universit?t MünchenMunich Germany;

    Department of NeurologyMedical University InnsbruckInnsbruck Austria;

    Department of NeurologyMedical University InnsbruckInnsbruck Austria;

    Memory and Aging Center Department of NeurologyUniversity of CaliforniaSan Francisco California USA;

    Department of NeurologyRutgers Robert Wood Johnson Medical SchoolNew Brunswick New Jersey USA;

    Department of NeurologyMayo ClinicRochester Minnesota USA;

    Department of NeurologyUniversity of CaliforniaSan Diego California USA;

    Department of Clinical NeuroscienceUCL Institute of NeurologyQueen Square London UK;

    Department of RadiologyMayo ClinicRochester Minnesota USA;

    Parkinson's Disease &

    Movement Disorders UnitHospital Clínic/IDIBAPS/CIBERNED/European Reference;

    Sorbonne Université INSERM CNRS Assistance Publique H?pitaux de Paris ICM H?pital Pitié‐Salp;

    The Edmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement;

    Department of Clinical Neurosciences and Cambridge Centre for Parkinson‐PlusCambridge;

    Department of NeurologyTechnische Universit?t MünchenMunich Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 神经病学 ;
  • 关键词

    autopsy; diversity; phenotype; progressive supranuclear palsy;

    机译:尸检;多样性;表型;进行性胰腺麻痹;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号